COMPANY PROFILE

Ansa Biotechnologies

Explore full profile

Enabling the next generation of DNA synthesis using enzymes

Emeryville, United StatesFounded 2018Biotech & Life Sciences

Valuation $250–500M Last recorded · 2025

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Ansa Biotechnologies

Ansa Biotechnologies is a startup that operates in the biotechnology sector, specifically in the area of DNA synthesis. The company is developing an innovative method to synthesize DNA, which has the potential to significantly speed up advancements in various fields such as medicine, agriculture, and industrial biotechnology.

The company's proprietary enzymatic DNA synthesis technology is designed to overcome the limitations of traditional DNA synthesis methods. This technology enables the production of gene-length molecules directly, bypassing the bottlenecks typically associated with conventional DNA synthesis. This means that complex DNA sequences can be accessed more quickly and reliably, which could have far-reaching implications for scientific research and development.

Ansa Biotechnologies primarily serves scientists and researchers who require DNA synthesis for their work. This includes those working in sectors such as healthcare, where DNA synthesis could be used to develop new treatments for diseases, and agriculture, where it could be used to create more resilient crops.

The company's business model is based on providing its DNA synthesis technology as a service. Customers pay for the DNA sequences that Ansa Biotechnologies synthesizes using its proprietary technology. The company generates revenue from these transactions.

In a recent podcast, CEO Dan Lin-Arlow discussed the company's history and technology, highlighting the challenges of synthesizing long DNA and the impact of computation and AI on the demand for DNA synthesis.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Emeryville, United States
Employees: 75
Open positions: 5
Dealroom signal: 69.4/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, DNA, Genetics and genomics, Spinout, Biotech and Pharma, YC W20, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Oct 2025	$54M	$340M	Altitude Life Science Ventures · Fall Line Capital · Blue Water Life Science · Black Opal Ventures	↗
SERIES AOther financing	Apr 2022	$68M	$272M	PEAK6 · Altitude Life Science Ventures · Fifty Years · RA Capital Management	↗

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Ansa Biotechnologies website traffic

Latest recorded traffic for Ansa Biotechnologies is 13K monthly website visits, down 45.8% over the last three months. Ansa Biotechnologies's team grew 11.9% over the past year.

Latest monthly visits13K 3-month web change-45.8% 1-year team growth+11.9%

Monthly website visitsMar 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

TEMPORARY CONTRACTOR - Manufacturing Associate, DNA Synthesis : Sunday - Wednesday, Swing Shift New Emeryville, CAEmeryville, California, United States, Northern America, Americas · Other · Sep 4, 2026 Manufacturing Scientist, Reagent Manufacturing Emeryville, CAEmeryville, California, United States, Northern America, Americas · Other · Aug 28, 2026 Manufacturing Scientist, Reagent ManufacturingEmeryville, CA · Other · Aug 26, 2026 Research Associate, Molecular Biology New Emeryville, CAEmeryville, California, United States, Northern America, Americas · Other · Aug 21, 2026 Director of AccountingEmeryville, California, United States, Northern America, Americas · Accounting · Aug 7, 2026 Lead Manufacturing Associate, DNA Synthesis - SWING SHIFTEmeryville, CA · Other · Aug 5, 2026 Digital Marketing ManagerEmeryville, California, United States, Northern America, Americas · Marketing & Communication · Jul 30, 2026 Staff Software Systems DeveloperEmeryville, CA · Backend Development · Jul 30, 2026

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational	11	$3.4M	$7M
FEFemtogenixDNA-interactive payloads for antibody-drug conjugates	St Albans, United Kingdom	Operational
IPIndex PharmaceuticalsDeveloping drugs to treat inflammatory bowel disease that can help patients return to a normal life	Solna kommun, Sweden	Operational
PGPhase GenomicsPhase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes	Seattle, United States	Operational
FLFluorofinderOnline service for designing medical research experiments	Boulder, United States	Operational
PIPierianDxEnables clinical labs to deliver patient-specific diagnosis and treatments	St. Louis, United States	Acquired
CACATALOGA developer of a data conversion and storage platform used to offer the next generation of digital data archives	Boston, United States	Operational
CICirinaAt Cirina we are pioneering products that detect cancer at its earliest stages and empower you to take action	New York City, United States	Operational